Susana Ravassa1, Tatiana Kuznetsova2, Nerea Varo3, Lutgarde Thijs2, Christian Delles4, Anna Dominiczak4, Javier Díez5, Jan A Staessen6. 1. Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, IdiSNA-Navarra Institute for Health Research, Pamplona, Spain. 2. The Studies Coordinating Centre, Research Unit of Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium. 3. Department of Biochemistry, University of Navarra Clinic, University of Navarra, IdiSNA-Navarra Institute for Health Research, Pamplona Spain. 4. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, UK. 5. Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, IdiSNA-Navarra Institute for Health Research, Pamplona, Spain; Department of Cardiology and Cardiac Surgery, University of Navarra Clinic, University of Navarra, IdiSNA-Navarra Institute for Health Research, Pamplona, Spain. Electronic address: jadimar@unav.es. 6. The Studies Coordinating Centre, Research Unit of Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium; Department of Epidemiology, University of Maastricht, Maastricht, The Netherlands. Electronic address: jan.staessen@med.kuleuven.be.
Abstract
BACKGROUND/ OBJECTIVES: The validation of effective screening tools for the identification of patients with subclinical myocardial remodelling is a major clinical need. Thus, we explored the associations of circulating biomarkers of cardiomyocyte injury and stress with subclinical cardiac remodelling and dysfunction, and with biomarkers reflecting collagen turnover. METHODS: We randomly recruited 727 subjects from a general population (51.2% women; mean age 51.3 years). Measurements included echocardiographic left atrial (LA) and left ventricular (LV) structure and function, quantification of high sensitivity cardiac Troponin T (hs-cTnT), NT-proBNP, and biomarkers of collagen types I and III turnover. RESULTS: In unadjusted and adjusted analyses, the prevalence of LA enlargement (LAE), LV hypertrophy (LVH) and LV diastolic dysfunction (LVDD) increased with higher hs-cTnT (P ≤ 0.031). NT-proBNP was independently associated with LVDD (P=0.009). Both biomarkers combined yielded significant integrated discrimination and net reclassification improvements (P ≤ 0.014 and P ≤ 0.009, respectively) for LAE, LVH and LVDD, over the conventional risk factors, and were independently and positively associated with biomarkers of collagen type I turnover. In a sensitivity analysis, after excluding participants with previous cardiac diseases, our findings remained consistent. CONCLUSIONS: Our population-based study suggested that subclinical LV and LA remodelling were associated with hs-cTnT, and that, in combination with NT-proBNP, hs-cTnT showed incremental diagnostic utility over the conventional risk factors. Both biomarkers were associated with biomarkers of collagen type I turnover. Thus, biomarkers of cardiomyocyte microinjury and hemodynamic stress may stimulate fibrosis-related mechanisms and facilitate the diagnosis of subclinical LA and LV remodelling and dysfunction in the general population.
RCT Entities:
BACKGROUND/ OBJECTIVES: The validation of effective screening tools for the identification of patients with subclinical myocardial remodelling is a major clinical need. Thus, we explored the associations of circulating biomarkers of cardiomyocyte injury and stress with subclinical cardiac remodelling and dysfunction, and with biomarkers reflecting collagen turnover. METHODS: We randomly recruited 727 subjects from a general population (51.2% women; mean age 51.3 years). Measurements included echocardiographic left atrial (LA) and left ventricular (LV) structure and function, quantification of high sensitivity cardiac Troponin T (hs-cTnT), NT-proBNP, and biomarkers of collagen types I and III turnover. RESULTS: In unadjusted and adjusted analyses, the prevalence of LA enlargement (LAE), LV hypertrophy (LVH) and LV diastolic dysfunction (LVDD) increased with higher hs-cTnT (P ≤ 0.031). NT-proBNP was independently associated with LVDD (P=0.009). Both biomarkers combined yielded significant integrated discrimination and net reclassification improvements (P ≤ 0.014 and P ≤ 0.009, respectively) for LAE, LVH and LVDD, over the conventional risk factors, and were independently and positively associated with biomarkers of collagen type I turnover. In a sensitivity analysis, after excluding participants with previous cardiac diseases, our findings remained consistent. CONCLUSIONS: Our population-based study suggested that subclinical LV and LA remodelling were associated with hs-cTnT, and that, in combination with NT-proBNP, hs-cTnT showed incremental diagnostic utility over the conventional risk factors. Both biomarkers were associated with biomarkers of collagen type I turnover. Thus, biomarkers of cardiomyocyte microinjury and hemodynamic stress may stimulate fibrosis-related mechanisms and facilitate the diagnosis of subclinical LA and LV remodelling and dysfunction in the general population.
Authors: Xiaoyang Li; Tatiana Kuznetsova; Nicholas Cauwenberghs; Matthew Wheeler; Holden Maecker; Joseph C Wu; Francois Haddad; Hongjie Dai Journal: Proc Natl Acad Sci U S A Date: 2017-06-19 Impact factor: 11.205
Authors: Annemarie Wentzel; Leoné Malan; Wayne Smith; Roland von Känel; Nicolaas T Malan Journal: Transl Stroke Res Date: 2018-11-09 Impact factor: 6.829
Authors: Priit Pauklin; Mihkel Zilmer; Jaan Eha; Kaspar Tootsi; Mart Kals; Priit Kampus Journal: Oxid Med Cell Longev Date: 2022-05-23 Impact factor: 7.310
Authors: Tom Hendriks; Minke H T Hartman; Pieter J J Vlaar; Niek H J Prakken; Yldau M Y van der Ende; Chris P H Lexis; Dirk J van Veldhuisen; Iwan C C van der Horst; Erik Lipsic; Robin Nijveldt; Pim van der Harst Journal: Int J Cardiovasc Imaging Date: 2017-04-07 Impact factor: 2.357
Authors: Tom Kai Ming Wang; Clementina Dugo; Yvonne Gillian; Wynne Yvonne; Semple Heather; Smith Kevin; Cleave Peter; Christiansen Jonathan; To Andrew; Amir Nezar; Tony Scott; Boswell Ross; Gladding Patrick Journal: Med Sci (Basel) Date: 2018-02-15
Authors: Qi-Fang Huang; Sander Trenson; Zhen-Yu Zhang; Jan Van Keer; Lucas N L Van Aelst; Wen-Yi Yang; Esther Nkuipou-Kenfack; Lutgarde Thijs; Fang-Fei Wei; Blerim Mujaj; Agnieszka Ciarka; Walter Droogné; Johan Vanhaecke; Stefan Janssens; Johan Van Cleemput; Harald Mischak; Jan A Staessen Journal: Transplant Direct Date: 2018-04-23
Authors: Mariya Kuk; Simon Newsome; Francisco Alpendurada; Marc Dweck; Dudley J Pennell; Vassilios S Vassiliou; Sanjay K Prasad Journal: JRSM Cardiovasc Dis Date: 2020-04-27
Authors: Sharon Remmelzwaal; Adriana J van Ballegooijen; Linda J Schoonmade; Elisa Dal Canto; M Louis Handoko; Michiel T H M Henkens; Vanessa van Empel; Stephane R B Heymans; Joline W J Beulens Journal: BMC Med Date: 2020-10-30 Impact factor: 8.775